Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
TrkA Blocking Peptide (AC1308)
Cat.#: ACPP-1308
Specifications
Despition TrkA Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1834 Human BAALC Protein (AC1834) 2 µg inquiry ACPP-1486 Rat VEGF C Protein (AC1486) 2 µg inquiry ACPP-1174 Synthetic Nanodisc Human CD97 Protein (AC1174) 10 µg inquiry ACPP-1621 Human LZIC Protein (AC1621) 5 µg inquiry ACPP-1166 Recombinant Human VCAM1 Protein (Fc Tag) (AC1166) 50 µg inquiry ACPP-1179 Recombinant Human Gastrin Releasing Peptide Protein (Fc Tag) (AC1179) 50 µg inquiry ACPP-1733 Human CRYGC Protein (AC1733) 5 µg inquiry ACPP-1203 ADCY8 Blocking Peptide (AC1203) 250 µg inquiry ACPP-1276 MAP3K4 Blocking Peptide (AC1276) 250 µg inquiry ACPP-1569 Human SOX2 Protein (AC1569) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket